https://doctransparency.com/doctor/fl/melbourne/boris-havkin-1609867696
Medicare Enrolled

Dr. Boris Havkin, MD

Urology Physician · Melbourne, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3021 W EAU GALLIE BLVD, Melbourne, FL 32934
3215004545
In practice since 2005 (20 years)
NPI: 1609867696 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Havkin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Havkin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Havkin

Dr. Boris Havkin is an urology physician in Melbourne, FL, with 20 years in practice. Based on federal Medicare data, Dr. Havkin performed 169,215 Medicare services across 4,209 unique beneficiaries.

Between the years covered by Open Payments, Dr. Havkin received a total of $3,601 from 26 pharmaceutical and/or device companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Havkin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 0% volume in FL$ $3,601 industry payments

Medicare Practice Summary

Medicare Utilization ↗
169,215
Medicare services
Top 0% in FL for urology physician
4,209
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,461 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone injection141,162$0$0
Unclassified drugs19,584$89$188
Drug injection, under skin or into muscle1,337$10$70
Bladder ultrasound after voiding1,200$8$50
Electronic assessment of bladder emptying1,148$7$200
Placement of hormone pellet under skin1,091$69$225
Ceftriaxone antibiotic injection1,044$0$1
Office visit, established patient (30-39 min)726$90$274
Office visit, established patient, complex (40-54 min)483$130$359
Insertion of implant in urethra within prostate gland using an endoscope, each additional implant193$627$2,345
Diagnostic exam of bladder and urethra using an endoscope124$174$636
Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope122$163$875
Injection, tobramycin sulfate, up to 80 mg115$2$4
Leuprolide acetate (for depot suspension), 7.5 mg111$135$282
Ultrasound scan of pelvic region through rectum86$101$333
Injection, ketorolac tromethamine, per 15 mg85$0$2
Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope80$448$1,615
New patient office visit, complex (60-74 min)53$151$515
Complex measurement of pressure of urine flow in bladder with voiding pressure studies45$278$630
Insertion of device into abdomen with pressure and urine flow rate study45$147$300
Insertion of implant in urethra within prostate gland using an endoscope, 1 implant38$933$2,500
Biopsy of prostate gland38$187$596
Ultrasonic guidance for needle placement38$45$455
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle37$24$130
Crushing, fragmenting, and removal of bladder stones, less than 2.5 cm36$678$1,900
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm35$548$2,175
New patient office visit (45-59 min)31$118$466
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional31$18$61
Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming23$36$175
Exam with injections of chemical for destruction of bladder using an endoscope22$117$1,333
Simple bladder irrigation and/or instillation21$30$166
Dilation of urethra using an endoscope16$205$617
Office visit, established patient (20-29 min)15$69$182
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,601
Total received (2018-2024)
Avg $514/year across 7 years
Top 50% in FL for urology physician
26
Companies
138
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,958 (82.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$643 (17.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$510
2023
$380
2022
$752
2021
$295
2020
$289
2019
$528
2018
$848

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$810
Valencia Technologies Corporation
$644
NeoTract Inc.
$407
Teleflex LLC
$383
Endo Pharmaceuticals Inc.
$249
Medtronic USA, Inc.
$236
Janssen Biotech, Inc.
$119
Medtronic, Inc.
$106
Laborie Medical Technologies Corp.
$95
PFIZER INC.
$82
180 Medical, Inc.
$80
Boston Scientific Corporation
$77
Allergan Inc.
$60
ABBVIE INC.
$55
Coloplast Corp
$26
Allergan, Inc.
$24
AbbVie, Inc.
$19
Ferring Pharmaceuticals Inc.
$18
Avadel Specialty Pharmaceuticals, LLC
$16
Olympus America Inc.
$16
Accord Healthcare, Inc.
$16
Rochester Medical Corporation
$14
Antares Pharma, Inc.
$13
Acerus Pharmaceuticals Corporation
$12
Blue Earth Diagnostics Limited
$12
Axonics Modulation Technologies, Inc.
$11
Top 3 companies account for 51.7% of total payments
Associated products mentioned in payments ›
Androgel · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CONTINENCE CARE · ERLEADA · Erleada · GELFOAM · GENTLECATH · INTERSTIM · INTERSTIM ICON · LITHOVUE · LUPRON DEPOT · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Otrexup · REZUM · SpaceOAR VUE System - 10mL · TESTOPEL · UROLIFT · UroLift · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · Xtandi · ZYTIGA · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a urology physician in Melbourne?
Compare urology physicians in the Melbourne area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
28
Per 100K population
4.5
County median income
$75,817
Nearest hospital
ORLANDO HEALTH MELBOURNE HOSPITAL
4.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Havkin is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Havkin experienced with testosterone injection?
Based on Medicare claims data, Dr. Havkin performed 141,162 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Havkin receive payments from pharmaceutical companies?
Yes. Dr. Havkin received a total of $3,601 from 26 companies across 138 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Havkin's costs compare to other urology physicians in Melbourne?
Dr. Havkin's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Havkin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →